Drug Trial Radar · NCT04739293
Study of ON 123300 in Patients With Advanced Cancer
Last checked: Nov 19, 2026Latest source record: Dec 7, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
36
Planned (sponsor's estimate)
Start
May 13, 2021
Primary completion
Oct 2024
Study completion Oct 2024
Sponsor
- Lead sponsor
- Traws Pharma, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 4, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will investigate the safety of the drug ON 123300 at increasing doses to determine the best dose to use in future clinical trials.
Conditions
- Solid Tumors, Adult
Interventions
ON123300Drug
ON 123300 hard gelatin capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Dose Limiting Toxicities (DLT)Time frame: First 28 days of dosing
- Incidence of adverse events (AE)Time frame: Consent to 30 days after last dose
- Abnormal Laboratory Test resultsTime frame: Consent to 30 days after last dose
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
START Midwest
Grand Rapids, Michigan · Recruiting
Greenville Health System, Institute for Oncology Clinical Research
Greenville, South Carolina · Recruiting
Mary Crowley Cancer Research
Dallas, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.